GLS and cancer: Glutaminolysis is frequently elevated in cancer, and accumulating evidence indicates that its inhibition is effective for targeting glutamine-addicted cancers.5 Glutaminase (GLS), which catalyzes the deamination of glutamine to glutamate, is the most extensively studied drug target in this pathway.